CDC42 and Parkinson disease: Additional predictions involve neuro-immune signaling, with a specific focus on the CDC42 Rho GTPase which functions both in controlling anxiety and in defense against viral infection and general immune cell activities, both phenomena known in PD patients and which emerged in our network analysis as changed in the disease.